Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
about
Plant sterols as anticancer nutrients: evidence for their role in breast cancerGlucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinomaCeramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancerAltered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 statusTherapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.GCS overexpression is associated with multidrug resistance of human HCT-8 colon cancer cells.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.Ceramide phosphoethanolamine synthase SMSr is a target of caspase-6 during apoptotic cell death.Runx regulation of sphingolipid metabolism and survival signaling.Monitoring Changes in the Oligomeric State of a Candidate Endoplasmic Reticulum (ER) Ceramide Sensor by Single-molecule Photobleaching.Translational Aspects of Sphingolipid Metabolism in Renal Disorders.TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.
P2860
Q26861053-44A399B6-666D-4F69-ADB0-55BA4F87D956Q33683147-41172200-3B34-4AAA-A549-6D076E37C65AQ33733991-41600959-5BB6-4836-B2BA-7C4F66D3EB86Q34469733-25F6B4BC-76E8-4152-9D9D-F19CF026ED99Q37392829-E7B8E309-7C09-432B-A7C3-D7F7AA512B9BQ37685348-4AEB4BE1-1A48-4888-81A5-B921FB69C36CQ38052818-4D1DE64F-25A9-4832-A8A7-1B813B103E6FQ39378630-72FDACCA-0321-48C1-BCB9-A6E085DBB431Q39421907-0A4FD6CA-ECAA-4BAD-82B3-71134E1860C3Q39549312-AE67BD04-342C-41B7-9F4D-93049C69B3DFQ41488650-FD470BF5-F009-4EC8-AB95-9AE1F61F9CD4Q42722380-84C6481C-0855-400E-92AB-7A3F3E85B819Q47133063-5F83B311-10C2-4560-ADFB-19E347EDD537Q49399657-D2FE74EE-D73C-4D22-89B2-B0B89F17D979Q50847783-63635DD2-C2A8-47F2-BD31-E37A84D7E7EF
P2860
Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Co-suppression of MDR1 (multid ...... ls by RNA interference (RNAi).
@en
Co-suppression of MDR1
@nl
type
label
Co-suppression of MDR1 (multid ...... ls by RNA interference (RNAi).
@en
Co-suppression of MDR1
@nl
prefLabel
Co-suppression of MDR1 (multid ...... ls by RNA interference (RNAi).
@en
Co-suppression of MDR1
@nl
P2093
P356
P1476
Co-suppression of MDR1 (multid ...... ls by RNA interference (RNAi).
@en
P2093
Genyin Zhou
Xiaofang Zhang
Xiaojuan Wu
Zhengang Qiu
P304
P356
10.4161/CBT.8.12.8374
P577
2009-06-09T00:00:00Z